Vaso Gentech Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -13.75%
- Profit Growth -0.00%
- Ebitda 2.06%
- Net Worth 39.43%
- Total Assets -3.04%
About Vaso Gentech
Vaso Gentech Private Limited (VGPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2004 and has a history of 20 years and three months. Its registered office is in Chennai 600021, Tamil Nadu.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramasamy Subramanian and Priya Ramasamy serve as directors at the Company.
Company Details
-
LocationChennai 600021, Tamil Nadu
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51507TN2004PTC054504
-
Company No.
054504
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Vaso Gentech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Subramanian
|
Director | 15-Oct-2004 | Current |
|
Priya Ramasamy
|
Director | 15-Oct-2004 | Current |
Financial Performance of Vaso Gentech.
Vaso Gentech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.75% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 39.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaso Gentech?
In 2020, Vaso Gentech had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vaso-Meditech Private LimitedRamasamy Subramanian and Priya Ramasamy are mutual person
-
4R Health & Wellness LlpRamasamy Subramanian and Priya Ramasamy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaso Gentech?
Unlock and access historical data on people associated with Vaso Gentech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaso Gentech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaso Gentech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.